Replay: Treating Adolescent Depression with DTx

In this episode, we hear from Benjamin Alouf, MD, Chief Medical Officer at Limbix. In their own words, Limbix is the first digital therapeutic for adolescent depression.  Big Health, the leading provider of non-drug digital treatments for mental health, has now acquired Limbix. In addition to health care providers, SparkRx will be made available to Big Health’s employer, public sector, health systems and health plan customers, and through the company’s strategic distribution agreements with pharmacy benefit managers (PBMs), significantly increasing nationwide access. In this episode, we cover: Origin of the company and story behind the name 'Limbix' The funding journey and key milestones achieved The choice to focus on the young adult population in particular Patient experience with SparkRx Defining good patient engagement in adolescent mental health Evidence generation and FDA submission process Business hypthothesis and scaling plan The future of the PDT market Guest Links and Resources: Connect with Benjamin Alouf, MD on LinkedIn Visit Limbix.com Episode PDF Big Health Expands into Adolescent Mental Health Through Acquisition of Limbix Host Links: Eugene Borukhovich: Twitter | LinkedIn Chandana Fitzgerald, MD: Twitter | LinkedIn YourCoach.health: Website | Twitter Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Partners and Sponsors: Akili | Bayer G4A | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram